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Abstract
Statistical analyses presented in general medical journals are becoming increasingly sophisticated. BMC Medicine
relies on subject reviewers to indicate when a statistical review is required. We consider this policy and provide
guidance on when to recommend a manuscript for statistical evaluation. Indicators for statistical review include
insufficient detail in methods or results, some common statistical issues and interpretation not based on the
presented evidence. Reviewers are required to ensure that the manuscript is methodologically sound and clearly
written. Within that context, they are expected to provide constructive feedback and opinion on the statistical
design, analysis, presentation and interpretation. If reviewers lack the appropriate background to positively confirm
the appropriateness of any of the manuscript’s statistical aspects, they are encouraged to recommend it for expert
statistical review.
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Introduction
Most papers published in general medical journals, includ-
ing BMC Medicine, contain some element of statistical
methods, analysis and interpretation. There is evidence that
statistical analyses are becoming increasingly sophisticated
[1]. Expert statistical review has therefore become an
integral part of the editorial process. Some journals send
all manuscripts for statistical review. Other journals only
send a manuscript for statistical review if it is considered
necessary; for example, if the methods are particularly
complex or if the Editor or subject reviewer has concerns.
The approach taken by BMC Medicine is to ask subject re-
viewers if they are able to assess all the statistical aspects
of the manuscript themselves or whether they recommend
an additional statistical review.
One potential weakness of this approach is that it is a
system that relies heavily upon the statistical expertise of
subject reviewers, who may not have a formal qualification
or professional accreditation in statistics. As such, the
subject reviewer may be competent in a specific range
of statistical methods applicable to their area of expertise,
but may not necessarily be aware of more general statistical
issues or more recent methodological developments and
best practices. The subject reviewer may be able to spot
the most egregious errors but is likely to miss the subtlety
of inappropriate statistics that might be picked up by an
appropriately qualified statistical expert. The aim of this
paper is to provide subject reviewers with some help in
deciding when a manuscript might benefit from undergo-
ing a proper statistical review. Our comments mainly refer
to review of primary research, rather than to systematic
reviews and meta-analysis, for which a separate tutorial is
available [2].
Statistical review is an important element of the peer-
review process that has been shown to substantially im-
prove the quality of manuscripts [3–5]. This relates not
only to the statistical analysis, but also to other relevant
areas, such as data sources, study design, presentation of
results and interpretation of results [1, 6].
We argue that sending a paper for statistical review
should not be limited to studies where the subject reviewer
considers the methods to be potentially incorrect, or
beyond their expertise. Rather, the subject reviewer should
generally recommend expert statistical review unless they
can positively confirm that there are no problems with the
study design, statistical analysis, presentation and inter-
pretation of results.
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Although some statistical irregularities are subtle and
only likely to be detected by a statistical expert, subject
reviewers should consider some of the following indicators
of the more common problems encountered in primary
research:
Is there sufficient detail to review the statistical aspects?
 Have the relevant reporting guidelines been followed
(for example, CONSORT for randomized controlled
trials [7] or STROBE for observational studies [8])?
 Have the authors justified their sample size and
made reasonable assumptions about the effect size
they consider important to detect? Have they
presented enough information to verify their
calculations [9]?
 Have the methods been provided in sufficient detail
to replicate the results if the data were available
[1, 10, 11]?
 Is it clear how all the results were derived, such as
the test or model used, including any covariates, and
were the assumptions made in implementing the
model reasonable?
Are there any common statistical issues?
 Are there lots of P values, or subgroup analyses,
particularly unplanned subgroup analyses that were
not pre-specified, indicating multiple testing [12]?
 Are the covariates adjusted for in models appropriate,
without remaining confounding, or over-adjustment
for covariates on the causal pathway (for example,
longitudinal studies where a covariate is measured
after the exposure)?
 Are there any hierarchical data structures (for
example, cluster randomized trials, repeated
measures or matching of cases and controls), and if
so has the analysis taken this into account?
 Should the analysis address agreement rather than
association [13]?
 Has the intention-to-treat principle been appropriately
applied in pragmatic effectiveness trials [14, 15]?
 Have continuous variables been categorized? Have
trends been ignored? This may not necessarily mean
an inappropriate analysis, but may indicate that a
full statistical review would be beneficial.
Is the presentation of results appropriate?
 Is there any evidence of selective reporting? Do the
main results focus on the main research question, or
do they deviate to a secondary question or subgroup?
This is particularly problematic if the subgroup analysis
was not specified prior to undertaking the analysis [12].
 Are results presented without estimates, just
P values [16]?
 Are estimates presented with no confidence
intervals? Standard errors alone are rarely adequate
for presenting the uncertainty in estimates, either in
the text or graphically [16].
Is the interpretation of results appropriate?
 Are limitations of observational studies correctly
acknowledged, with no implication of causality in
the wording of results and conclusions?
 Are results over-extrapolated, beyond the range of
the data, or to populations not represented by the
study sample?
 Is there an appropriate consideration of the impact
of any incomplete or missing data?
Although there might be alternative approaches to
statistical analysis or presentation, this does not neces-
sarily imply the authors’ methods are invalid. What is
important is that the methods chosen are appropriate
for the research question and have been done correctly
[17]. BMC Medicine allows comments under “discretionary
revisions” where such observations can be made.
The same caution we recommend to non-statistical re-
viewers also applies to statistical experts. Statistical methods
are many and varied, particularly in a general medical
journal such as BMC Medicine. Some of the more spe-
cialist methods may be outside of the experience of a
general statistical reviewer. Consequently they should be
encouraged to recommend that the editorial office ap-
proach an additional specialist in those particular methods
for further scrutiny of the article.
Conclusions
In advising the Editor on publication, reviewers are re-
quired to comment on whether a manuscript is methodo-
logically sound and clearly written. Within that context,
they are expected to provide clear, constructive feedback
and opinion on study design, statistical analysis, presenta-
tion and interpretation of results. We have provided a
number of indicators to assist the non-statistical reviewer
in this task. If reviewers lack the appropriate background
to positively confirm the appropriateness of any of the
manuscript’s statistical aspects, they are encouraged to
recommend it for expert statistical review.
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